CAS: 442908-10-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Vipadenant REF: AN-AG0039VLCAS: 442908-10-3 | 98% | To inquire | Mon 13 May 24 |
 | Vipadenant REF: TM-T2373CAS: 442908-10-3 | 98% | 40.00 €~1,105.00 € | Tue 21 May 24 |
 | Vipadenant REF: 3D-SSA90810CAS: 442908-10-3 | Min. 95% | To inquire | Tue 25 Jun 24 |
Ref: AN-AG0039VL
| 1g | To inquire | |
| 2mg | 47.00 € | |
| 5mg | 70.00 € | |
| 10mg | 115.00 € | |
| 25mg | 187.00 € | |
| 50mg | 226.00 € | |
| 100mg | 510.00 € | |
| 250mg | 611.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Vipadenant
CAS:442908-10-3
Vipadenant (CEB-4520)(BIIB-014) is an adenosine A2a antagonist with Ki of 1.3 nM; less potent for …
Formula:
C16H15N7O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
321.34
Ref: TM-T2373
| 1mg | 40.00 € | |
| 2mg | 57.00 € | |
| 5mg | 90.00 € | |
| 10mg | 123.00 € | |
| 25mg | 211.00 € | |
| 50mg | 348.00 € | |
| 100mg | 515.00 € | |
| 500mg | 1,105.00 € | |
| 1ml*10 (DMSO) | 352.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Vipadenant
CAS:442908-10-3
Vipadenant is a new drug that has been developed for the treatment of cancer. It …
Formula:
C16H15N7O
Purity:
Min. 95%
Molecular weight:
321.34 g/mol
Ref: 3D-SSA90810
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Jun 2024
